These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 36472104)

  • 1. N6-Methyladenosine-Modification-Related Ophthalmic Diseases and Potential Therapeutic Strategies.
    Chen X; Xie Y; Liu Q; Luo X; Gao Y
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):304. PubMed ID: 36472104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential.
    Sun Y; Jin D; Zhang Z; Ji H; An X; Zhang Y; Yang C; Sun W; Zhang Y; Duan Y; Kang X; Jiang L; Zhao X; Lian F
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194967. PubMed ID: 37553065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis.
    Zhai G; Xiao L; Jiang C; Yue S; Zhang M; Zheng J; Liu Z; Dong Y
    Front Cell Dev Biol; 2022; 10():946219. PubMed ID: 35846376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progress on the role of N6-methyladenosine methylation in the pathogenesis and development of respiratory diseases].
    Li H; Yang J; Qin Y; Li J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Mar; 36(3):303-307. PubMed ID: 38538361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-methyladenosine methylation in kidney injury.
    Wang Q; Fan X; Sheng Q; Yang M; Zhou P; Lu S; Gao Y; Kong Z; Shen N; Lv Z; Wang R
    Clin Epigenetics; 2023 Oct; 15(1):170. PubMed ID: 37865763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress on N6-methyladenosine in the human placenta.
    Zhou W; Xue P; Yang Y; Xia L; Yu B
    J Perinat Med; 2022 Oct; 50(8):1115-1123. PubMed ID: 35606944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine methylation in ophthalmic diseases: From mechanisms to potential applications.
    Li B; Wang Z; Zhou H; Zou J; Yoshida S; Zhou Y
    Heliyon; 2024 Jan; 10(1):e23668. PubMed ID: 38192819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic role of N6-methyladenosine (m6A) RNA methylation in the cardiovascular system.
    Zhao K; Yang CX; Li P; Sun W; Kong XQ
    J Zhejiang Univ Sci B; 2020 Jul; 21(7):509-523. PubMed ID: 32633106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
    Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
    J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease.
    Cai T; Atteh LL; Zhang X; Huang C; Bai M; Ma H; Zhang C; Fu W; Gao L; Lin Y; Meng W
    Front Surg; 2022; 9():819335. PubMed ID: 35155557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis.
    Jiang X; Jin Z; Yang Y; Zheng X; Chen S; Wang S; Zhang X; Qu N
    Front Oncol; 2023; 13():1162300. PubMed ID: 37152066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of m6A modification in neurological diseases.
    Zhang Y; Zhang S; Shi M; Li M; Zeng J; He J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 47(1):109-115. PubMed ID: 35545370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulatory mechanisms of N6-methyladenosine modification in ferroptosis and its implications in disease pathogenesis.
    Tao X; Kang N; Zheng Z; Zhu Z; Ma J; He W
    Life Sci; 2024 Oct; 355():123011. PubMed ID: 39181316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenosine (m6A) modification in gynecological malignancies.
    Zhang C; Liu N
    J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.
    Chen M; Wong CM
    Mol Cancer; 2020 Feb; 19(1):44. PubMed ID: 32111216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer.
    Liu Q
    Front Genet; 2021; 12():825109. PubMed ID: 35087575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-methyladenosine (m6A) RNA modification in the pathophysiology of heart failure: a narrative review.
    Liu S; Wang T; Cheng Z; Liu J
    Cardiovasc Diagn Ther; 2022 Dec; 12(6):908-925. PubMed ID: 36605077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of N6-methyladenosine (m6A) in eye diseases.
    Gao JF; Zhang L
    Mol Biol Rep; 2021 Aug; 48(8):6145-6150. PubMed ID: 34331665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of m6A Ribonucleic Acid Modification in the Occurrence of Atherosclerosis.
    Fu J; Cui X; Zhang X; Cheng M; Li X; Guo Z; Cui X
    Front Genet; 2021; 12():733871. PubMed ID: 34603394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.